Novacyt SA
PAR:ALNOV

Watchlist Manager
Novacyt SA Logo
Novacyt SA
PAR:ALNOV
Watchlist
Price: 0.5 EUR -0.4% Market Closed
Market Cap: 35.3m EUR

Wall Street
Price Targets

ALNOV Price Targets Summary
Novacyt SA

There are no price targets for ALNOV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novacyt SA Competitors:
Price Targets
VYGR
Voyager Therapeutics Inc
423% Upside
ONCO
Oncopeptides AB
300% Upside
NGNE
Neurogene Inc
131% Upside
086900
Medy Tox Inc
33% Upside
XGN
Exagen Inc
2% Upside
688382
InventisBio Co Ltd
12% Downside
4882
Perseus Proteomics Inc
106% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
26% Upside

Revenue
Forecast

Revenue Estimate
Novacyt SA

For the last 8 years the compound annual growth rate for Novacyt SA's revenue is 3%. The projected CAGR for the next 1 year is 530%.

3%
Past Growth
530%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novacyt SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Novacyt SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALNOV's stock price target?
Not Available

ALNOV doesn't have any price targets made by Wall Street professionals.

What is Novacyt SA's Revenue forecast?
Projected CAGR
530%

For the last 8 years the compound annual growth rate for Novacyt SA's revenue is 3%. The projected CAGR for the next 1 year is 530%.

Back to Top